CD8A and melanoma: A study performed with melanoma, breast carcinoma, and colon carcinoma cells showed that the systemic degradation of Kyn reversed the effects of IDO1 in the tumor microenvironment and increased the tumor-infiltration and proliferation of CD8+ T cells [44], suggesting that IDO1 attenuates CD8+ T cell function and viability.